Public Company Management Corporation is a development stage company. The Company's business plan is to seek new business opportunities or to engage in a merger or acquisition with an unidentified company. The Companyâ€™s operations have been limited to seeking a potential business combination and has had no revenue from operations.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume

Real-time OTC Markets

More quotes

Market Closed - OTC Markets 02:25:18 14/05/26 am AEST			5-day change	1st Jan Change
0.4490 ^USD	+36.06%		+36.06%	+113.81%

05/08	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026	CI
12/05	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI

Market Cap	8.57M 7.34M 6.87M 6.29M 11.8M 820M 11.95M 81.15M 31.64M 412M 32.18M 31.48M 1.36B	P/E 2024	-89.4x	P/E 2025	-132x
Enterprise Value	8.68M 7.44M 6.96M 6.37M 11.96M 831M 12.12M 82.24M 32.07M 417M 32.61M 31.9M 1.38B	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	30.14%	Yield 2024 *	-	Yield 2025	-

05/08	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026	CI
12/05	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI
25/02	Public Company Management Corp. entered into a non-binding letter of intent to acquire Physicians Capital Management Corporation from Conrad Ivie, M.D.	CI
18/02	Public Company Management Corp. Reports Earnings Results for the First Quarter Ended December 31, 2025	CI
05/02	Public Company Management Corp. Reports Earnings Results for the Full Year Ended September 30, 2025	CI
04/02	Public Company Management Corp. Auditor Raises 'Going Concern' Doubt	CI
15/08/25	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2025	CI
10/05/25	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025	CI
12/02/25	Public Company Management Corp. Reports Earnings Results for the First Quarter Ended December 31, 2024	CI
13/01/25	Public Company Management Corp. Reports Earnings Results for the Full Year Ended September 30, 2024	CI
13/01/25	Public Company Management Corp. Auditor Raises 'Going Concern' Doubt	CI
10/08/24	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	CI
10/05/24	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI

05/02	Public Management : Annual Report for Fiscal Year Ending September 30, 2025 (Form 10-K)	PU
13/01/25	Public Management : Annual Report for Fiscal Year Ending September 30, 2024 (Form 10-K)	PU
03/08/23	Public Management : Change in Certifying Accountants - Form 8-K	PU
14/03/23	PUBLIC CO MANAGEMENT CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers, Other Events (form 8-K)	AQ
07/03/23	PUBLIC CO MANAGEMENT CORP : Change in Directors or Principal Officers (form 8-K)	AQ

Public Company Management Corp. Stock

Stocks

PCMC

US7443921017

Investment Holding Companies

Valuation: Public Company Management Corp.

Chart: Public Company Management Corp.

Latest news : Public Company Management Corp.

Press Releases: Public Company Management Corp.

Quotes and Performance

Course Extremes

Managers and Directors: Public Company Management Corp.

Shell Companies

Financials

Company Profile

Quotes

1 day	+36.06%
1 week	+36.06%
Current month	+12.25%
1 month	+12.25%
3 months	+9.51%
6 months	+114.83%
Current year	+113.81%

1 week	0.25	0.45
1 month	0.25	0.45
Current year	0.21	0.47
1 year	0.05	0.5
3 years	0.05	0.68
5 years	0	0.68
10 years	0	0.68

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PUBLIC COMPANY MANAGEMENT CORP.	+36.06%	+36.06%	-10.02%	+920.45%	8.57M
CHURCHILL CAPITAL CORP XI	+3.55%	-14.65%	-	-	812M
CENTIEL AG	-7.45%	-7.18%	+289.16%	-70.90%	658M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	0.00%	+0.10%	-	-	646M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.39%	+0.29%	-	-	600M
CHURCHILL CAPITAL CORP XII	-0.74%	-0.33%	-	-	595M
CANTOR EQUITY PARTNERS IV, INC.	-0.48%	-0.77%	+2.17%	-	591M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+0.52%	+1.21%	-	-	578M
CHURCHILL CAPITAL CORP XIII	0.00%	+0.67%	-	-	508M
Average	+3.45%	-2.31%	+93.77%	+424.78%	555.1M
Weighted average by Cap.	-0.47%	-3.21%	+152.22%	-58.15%

	2024	2025
Net sales	-	-
Net income	-75.52K -64.69K -60.53K -55.41K -104K -7.23M -105K -715K -279K -3.63M -284K -277K -12.01M	-104K -88.93K -83.21K -76.17K -143K -9.93M -145K -983K -383K -4.99M -390K -381K -16.5M
Net Debt	425K 364K 341K 312K 585K 40.66M 593K 4.02M 1.57M 20.43M 1.6M 1.56M 67.56M	116K 99.02K 92.65K 84.81K 159K 11.06M 161K 1.09M 427K 5.56M 434K 425K 18.38M